- Home
- CQP vs BNTX Comparison
CQP vs BNTX Comparison
Compare CQP & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CQP
- BNTX
- Stock Information
- Founded
- CQP 2003
- BNTX 2008
- Country
- CQP United States
- BNTX Germany
- Employees
- CQP N/A
- BNTX N/A
- Industry
- CQP Oil/Gas Transmission
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CQP Utilities
- BNTX Health Care
- Exchange
- CQP Nasdaq
- BNTX Nasdaq
- Market Cap
- CQP 28.1B
- BNTX 23.9B
- IPO Year
- CQP 2007
- BNTX 2019
- Fundamental
- Price
- CQP $52.29
- BNTX $111.50
- Analyst Decision
- CQP Sell
- BNTX Strong Buy
- Analyst Count
- CQP 4
- BNTX 15
- Target Price
- CQP $49.00
- BNTX $143.50
- AVG Volume (30 Days)
- CQP 142.8K
- BNTX 802.7K
- Earning Date
- CQP 10-31-2024
- BNTX 11-04-2024
- Dividend Yield
- CQP 6.08%
- BNTX N/A
- EPS Growth
- CQP N/A
- BNTX N/A
- EPS
- CQP 4.62
- BNTX N/A
- Revenue
- CQP $8,930,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- CQP N/A
- BNTX N/A
- Revenue Next Year
- CQP $13.54
- BNTX N/A
- P/E Ratio
- CQP $11.53
- BNTX N/A
- Revenue Growth
- CQP N/A
- BNTX N/A
- 52 Week Low
- CQP $45.51
- BNTX $76.53
- 52 Week High
- CQP $59.40
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- CQP 38.83
- BNTX 45.33
- Support Level
- CQP $56.11
- BNTX $112.91
- Resistance Level
- CQP $58.70
- BNTX $123.30
- Average True Range (ATR)
- CQP 1.78
- BNTX 4.70
- MACD
- CQP -0.72
- BNTX -0.62
- Stochastic Oscillator
- CQP 2.07
- BNTX 9.59
About CQP Cheniere Energy Partners LP Common Units
Cheniere Energy Partners is the direct owner of the Sabine Pass LNG terminals as well as regasification facilities. It also owns the Creole Trail Pipeline, which connects the terminal to third-party gas suppliers. Cheniere Partners shares in the marketing fees generated by Cheniere Marketing from Sabine Pass marketed gas volumes.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.